Pharmacovigilance (PV) Operations PEAK Matrix® Assessment
Everest Group
APRIL 7, 2025
Pharmaceutical companies now face a rapidly evolving landscape characterized by rising adverse event volumes, fragmented real-world data sources, and increasingly complex global regulatory frameworks. Regional variations in drug safety reporting requirements further compound compliance challenges across diverse markets.
Let's personalize your content